InHouse Medical LLC

09/01/2025

STAY AWAY FROM ULTRA-PROCESSED FOODS
A groundbreaking study from the University of Copenhagen reveals that ultra-processed foods contribute to fat gain, lower testosterone levels, and even introduce harmful chemicals— all WITHOUT increasing calorie intake.

👉 Men in the study gained more fat on processed foods compared to whole foods, even when calories, protein, carbs, and fats were identical.
👉 Hormones took a hit: testosterone and fertility markers dropped.
👉 Pollutants from packaging and processing were found in their bodies—linked to declining s***m quality.

At InHouse Medical, we see every day how diet, hormones, and health are connected. This research confirms what we emphasize with our patients: it’s not just about calories—it’s about the quality of your food.

If you’re struggling with weight gain, low energy, or hormone imbalance, our team can help you get answers through advanced lab testing and personalized treatment plans.

Visit us in Waterbury, CT, or schedule a telehealth consult today.

Learn more about our services at www.inhousemedicine.com

Source: University of Copenhagen. Why ultra-processed diets make you gain fat even without extra calories. ScienceDaily, August 30, 2025.

Call now to connect with business.

08/27/2025

Patients who are overweight or obese may have a lower risk of developing cancer if they take GLP-1 receptor agonists, according to research published in JAMA Oncology.
Researchers found that patients taking GLP-1 receptor agonists had a lower risk of cancer overall as well as lower risks of meningioma, endometrial cancer, and ovarian cancer.
This study is limited by its observational nature and by the lack of longitudinal assessments of BMI. Therefore, it’s not clear whether the apparent reduction in cancer risk was due to the GLP-1 receptor agonists themselves or the drug-induced weight loss.
www.inhousemedicine.com
https://www.cancertherapyadvisor.com/news/glp-1-receptor-agonists-risk-cancers/?utm_source=eloqua&utm_medium=email&utm_campaign=NWLTR_CTA_UPDT_RSS_LI-LAS1-LAS2-DI_10043_082725_RM&hmemail=T0Ku8v0kKjuqauKTZn2Npd%2FfndfC6gdj&sha256email=89a228e077dac9fd41f63b15e834e3fdad119dd46633442bc228d678c67266a1&hmsubid=jPmb3cqhEhw%3D&nid=1033414867&elqtrack=True

Patients taking GLP-1 receptor agonists had a lower risk of cancer overall as well as lower risks of certain cancers.

08/22/2025

Semaglutide Not Linked to Increased Risk for Eye Disorders, Diabetic Retinopathy
For adults with diabetes, semaglutide treatment is not associated with increased risk of eye disorders or diabetic retinopathy, according to a review published online Aug. 14 in JAMA Ophthalmology.
Additional studies dedicated to checking the relationship between semaglutide and NAION are needed.
(203)819-5232
InHouseMedicine.com

https://www.neurologyadvisor.com/news/semaglutide-not-linked-to-increased-risk-for-eye-disorders-diabetic-retinopathy/

For adults with diabetes, semaglutide treatment is not associated with increased risk of eye disorders or diabetic retinopathy.

08/21/2025

Wegovy (semaglutide), a GLP-1 medication, was recently cleared by the FDA as a treatment for a common liver disease, metabolic dysfunction-associated steatohepatitis, or MASH, with moderate to advanced liver scarring.
Wegovy helped improve liver scarring, or fibrosis, and resolve symptoms.
Besides obesity, Wegovy is also approved to cut the risk of heart complications. Novo also plans to seek approval of the drug to treat heart failure.
InHouseMedicine.com

https://www.statnews.com/2025/08/15/wegovy-mash-novo-nordisk/

Novo Nordisk’s obesity drug Wegovy was cleared by U.S. regulators to treat an increasingly common liver disease, MASH.

06/08/2025

Vitamin D is important for brain health, but this might be particularly true for women, it doesn’t appear to have this beneficial effect in men, according to early research.

"The large study showed an association between greater plasma vitamin D levels in females and better memory and larger subcortical brain structures."

https://www.medscape.com/viewarticle/vitamin-d-especially-important-brain-health-women-not-men-2025a1000daa?ecd=WNL_confwrapup_obgyn_ACOG-NON-SPON_250608_MSCPEDIT_etid7478428&uac=120040BV&impID=7478428

InHouse Medical
(203)518-5232
276 Highland Ave
Waterbury, CT 06708

Vitamin D is important for brain health, but this might be particularly true for women, early research suggests.

06/05/2025

FDA requires warning about rare but severe itching after stopping long-term use of oral allergy medicines cetirizine or levocetirizine (Zyrtec, Xyzal, and other trade names)
US Food and Drug Administration

05/28/2025

Researchers have distinguished the nerve cells in the brain that control the beneficial effects of GLP-1R agonists.
They believe this will enable them to distinguish the nerve cells in the brain that control the beneficial effects, such as reduced food intake and fat loss, from those that contribute to side effects.

Researchers have distinguished the nerve cells in the brain that control the beneficial effects of GLP-1R agonists – such as reduced food intake and fat loss – from those that contribute to side effects.

05/18/2025

If you have worked with InHouse Medical in the past and had a 5-star experience, please leave a Google review. Thank you!

https://g.page/r/CVusXu4f7wqyEBM/review

Post a review to our profile on Google

05/06/2025

Semaglutide found to have shocking benefit for liver disease patients in new study.

MASH is a severe form of metabolic dysfunction-associated steatotic liver disease (MASLD), which was previously known as non-alcoholic fatty liver disease.

After 72 weeks of treatment with semaglutide, 62.9% of participants had less inflammation and fat accumulation in their livers.
The researchers also found that 36.8% of the semaglutide group saw improvements in their liver fibrosis, versus 22.4% in the placebo group.
Participants treated with semaglutide also saw improvements in liver enzymes, blood measures of liver fibrosis, and 10.5% weight loss.
These are published findings in the NEJM.
www.inhousemedicine.com

We accept insurance. Obtain your Wegovy and Zepbound if you qualify from the pharmacy.

05/05/2025

Today, National Firefighters Day, we salute the brave men and women who run toward danger when others run away!
Thank you for your courage and service to our communities.

05/01/2025

For people to use CVS for their zepbound.

https://www.tiktok.com/t/ZTjBVxvx5/

178 likes, 73 comments. “Do you have CVS? How mad are you?”